Kevin G. Sarney
Interim Chief Financial OfficerMr. Kevin G. Sarney, CPA, has been the Interim Chief Financial Officer at Atara Biotherapeutics, Inc. since June 26, 2026. He served as Chief Financial Officer at GI Dynamics Inc until 2025. He served as Chief Financial Officer of LifeVault Bio, Inc until 2020. He had been an Interim Chief Executive Officer, Interim President and Director at Enumeral Biomedical Holdings, Inc. since June 29, 2017 and as its Chief Accounting Officer and Vice President of Finance since July 31, 2014. He served as Vice President of Finance and Administration at EIP Pharma, LLC until 2019. Mr. Sarney is an accomplished finance and accounting professional with many years of experience in the biotechnology industry in both early-stage and publicly traded companies. He served as Vice President of Finance and Administration at Avaxia Biologics, Inc. from September 2013 to July 2014. He worked as a consultant from May 2009 to August 2013 at various biotechnology and medical device companies in Interim Vice President of Finance and Controller roles. He served as the Corporate Controller and Principal Accounting Officer of Nitromed, Inc. from March 2005 to April 2009. At Nitromed, he was responsible for SEC reporting, financial planning, risk management, treasury, the initiation of the company's Sarbanes-Oxley compliance efforts and financial and accounting support for the launch of the company's first product, BiDil. During his career, he held the position of Audit Supervisor within the technology assurance group of PricewaterhouseCoopers LLP. He has inance and accounting experience with life science companies. Since January 2021, Mr. Sarney has served as a consultant at CRCFO, a provider of strategic and operational finance and accounting services for life science companies. Prior to joining CRCFO, Mr. Sarney served in executive finance positions with a number of publicly traded and privately held life science companies. Earlier in his career, Mr. Sarney was an auditor at PricewaterhouseCoopers. Mr. Sarney earned a B.S. in Business Management from the University of Hartford, an M.B.A. from Boston University and an M.A. in Accounting from Suffolk University. He is a Certified Public Accountant in the Commonwealth of Massachusetts.
Positions
- Company NameAtara Biotherapeutics, Inc.Stock CodeATRAPositionInterim Chief Financial Officer
